Table 1. Clinicopathological characteristics of study subjects (n = 100).
| Variable | Number of patients |
|---|---|
| Total | 100 |
| Mean age (range) | 51 (26 – 82 years) |
| Mean tumor size (range) | 3.094 (1 – 6 cm) |
| pT1 (≤2 cm) | 26 (28.5%) |
| pT2 (>2 – <5 cm) | 61 (67.0%) |
| pT3 (≥5 cm) | 4 (4.4%) |
| Axillary lymph nodal status | |
| Positive (%) | 43 (46.2%) |
| Negative (%) | 48 (52.7%) |
| Pathological Grade (%) | |
| Grade 1 | 09 (9.6%) |
| Grade 2 | 28 (30.1%) |
| Grade 3 | 56 (60.2%) |
| Breast cancer molecular subtype (%) | |
| ER+/PR+ | 38 (51.3%) |
| Triple positive | 06 (8.1%) |
| VHER 2 + | 09 (12.2%) |
| Triple-negative | 21 (28.3%) |
| Ki67 index: | |
| ≥14% | 17 (23.3%) |
| <14% | 56 (76.7%) |
| Type of surgery | |
| Mastectomy | 79 |
| Lumpectomy | 21 |